Wuhan Hiteck Biological Pharma Co.,Ltd (300683.SZ)

CNY 20.63

(3.67%)

Revenue Summary of Wuhan Hiteck Biological Pharma Co.,Ltd

  • Wuhan Hiteck Biological Pharma Co.,Ltd's latest annual revenue in 2023 was 602.28 Million CNY , down -12.54% from previous year.
  • Wuhan Hiteck Biological Pharma Co.,Ltd's latest quarterly revenue in 2024 Q3 was 166.36 Million CNY , up 10.34% from previous quarter.
  • Wuhan Hiteck Biological Pharma Co.,Ltd reported a annual revenue of 688.62 Million CNY in annual revenue 2022, up 12.03% from previous year.
  • Wuhan Hiteck Biological Pharma Co.,Ltd reported a annual revenue of 614.68 Million CNY in annual revenue 2021, up 17.28% from previous year.
  • Wuhan Hiteck Biological Pharma Co.,Ltd reported a quarterly revenue of 131.88 Million CNY for 2024 Q1, down -19.51% from previous quarter.
  • Wuhan Hiteck Biological Pharma Co.,Ltd reported a quarterly revenue of 166.36 Million CNY for 2024 Q3, up 10.34% from previous quarter.

Annual Revenue Chart of Wuhan Hiteck Biological Pharma Co.,Ltd (2023 - 2013)

Historical Annual Revenue of Wuhan Hiteck Biological Pharma Co.,Ltd (2023 - 2013)

Year Revenue Revenue Growth
2023 602.28 Million CNY -12.54%
2022 688.62 Million CNY 12.03%
2021 614.68 Million CNY 17.28%
2020 524.12 Million CNY -15.49%
2019 620.16 Million CNY 4.96%
2018 590.87 Million CNY -21.24%
2017 750.25 Million CNY -2.69%
2016 770.97 Million CNY 13.48%
2015 679.4 Million CNY 23.8%
2014 548.79 Million CNY 54.16%
2013 355.99 Million CNY 0.0%

Peer Revenue Comparison of Wuhan Hiteck Biological Pharma Co.,Ltd

Name Revenue Revenue Difference
Shenzhen Neptunus Bioengineering Co., Ltd. 36.41 Billion CNY 98.346%
Anhui Fengyuan Pharmaceutical Co., Ltd. 4.27 Billion CNY 85.913%
Dong-E-E-Jiao Co.,Ltd. 4.71 Billion CNY 87.227%
Livzon Pharmaceutical Group Inc. 12.27 Billion CNY 95.095%
Hainan Haiyao Co., Ltd. 1.45 Billion CNY 58.669%
Tus-Pharmaceutical Group Co., Ltd. 395.92 Million CNY -52.122%
Jilin Aodong Pharmaceutical Group Co., Ltd. 3.44 Billion CNY 82.538%
Changchun High-Tech Industries (Group) Inc. 14.46 Billion CNY 95.835%
Apeloa Pharmaceutical Co.,Ltd 11.47 Billion CNY 94.751%
PKU HealthCare Corp.,Ltd. 2.19 Billion CNY 72.546%
Chengdu Huasun Technology Group Inc., Ltd. 1 Billion CNY 39.974%
Dezhan Healthcare Company Limited 498.08 Million CNY -20.919%
Jinling Pharmaceutical Company Limited 2.78 Billion CNY 78.38%
Jiuzhitang Co., Ltd. 2.91 Billion CNY 79.369%
Huapont Life Sciences Co., Ltd. 11.59 Billion CNY 94.805%
Zhejiang Jingxin Pharmaceutical Co., Ltd. 3.95 Billion CNY 84.76%
Shandong Wohua Pharmaceutical Co., Ltd. 894.31 Million CNY 32.654%
Hengkang Medical Group Co., Ltd. 3.59 Billion CNY 83.226%
Guangdong Zhongsheng Pharmaceutical Co., Ltd. 2.61 Billion CNY 76.929%
Qianjiang Yongan Pharmaceutical Co., Ltd. 962.8 Million CNY 37.445%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. 5.42 Billion CNY 88.891%
Jinhe Biotechnology CO., LTD. 2.17 Billion CNY 72.298%
Teyi Pharmaceutical Group Co.,Ltd 1.06 Billion CNY 43.565%
Kunming Longjin Pharmaceutical Co., Ltd. 86.62 Million CNY -595.298%
Beijing Aosaikang Pharmaceutical Co., Ltd. 1.44 Billion CNY 58.275%
Chengdu Kanghong Pharmaceutical Group Co., Ltd 3.95 Billion CNY 84.781%
Anhui Huangshan Capsule Co., Ltd. 458.36 Million CNY -31.397%
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd 980.82 Million CNY 38.594%
Zhuhai Rundu Pharmaceutical Co., Ltd. 1.29 Billion CNY 53.379%
Huaren Pharmaceutical Co., Ltd. 1.63 Billion CNY 63.191%
Tianjin Ringpu Bio-Technology Co.,Ltd. 2.24 Billion CNY 73.219%
Shanxi Zhendong Pharmaceutical Co.,Ltd 3.62 Billion CNY 83.39%
Fuan Pharmaceutical (Group) Co., Ltd. 2.64 Billion CNY 77.253%
Hybio Pharmaceutical Co., Ltd. 431.38 Million CNY -39.617%
Baotou Dongbao Bio-Tech Co.,Ltd 974.51 Million CNY 38.196%
Hunan Er-Kang Pharmaceutical Co., Ltd 1.76 Billion CNY 65.957%
Changjiang Pharmaceutical Group Co., Ltd. 1.19 Billion CNY 49.707%
Zhejiang Garden Bio-chemical High-tech Co., Ltd. 1.09 Billion CNY 44.979%
Fujian Cosunter Pharmaceutical Co., Ltd. 422.71 Million CNY -42.48%
Beijing Science Sun Pharmaceutical Co., Ltd. 476.56 Million CNY -26.379%
Zhejiang Xinguang Pharmaceutical Co., Ltd. 270.39 Million CNY -122.738%
Hainan Poly Pharm. Co., Ltd 1.3 Billion CNY 53.83%
Jiangxi Synergy Pharmaceutical Co., Ltd. 722.13 Million CNY 16.597%
Shandong Xinhua Pharmaceutical Company Limited 8 Billion CNY 92.48%
Zhejiang Tianyu Pharmaceutical Co., Ltd. 2.52 Billion CNY 76.169%
PharmaBlock Sciences (Nanjing), Inc. 1.72 Billion CNY 65.089%
Jinghua Pharmaceutical Group Co., Ltd. 1.49 Billion CNY 59.59%
Zhejiang Hisoar Pharmaceutical Co., Ltd. 2.17 Billion CNY 72.269%
Betta Pharmaceuticals Co., Ltd. 2.45 Billion CNY 75.479%
Tibet AIM Pharm. Inc. 667.03 Million CNY 9.708%
Shenzhen Kangtai Biological Products Co., Ltd. 3.47 Billion CNY 82.68%
Shandong Shanda Wit Science and Technology Co., Ltd. 2.48 Billion CNY 75.755%
Pacific Shuanglin Bio-pharmacy Co., LTD 2.32 Billion CNY 74.137%
Zhejiang AngLiKang Pharmaceutical CO.,LTD. 1.62 Billion CNY 62.956%
Xiamen Kingdomway Group Company 3.1 Billion CNY 80.588%
ShanXi C&Y Pharmaceutical Group Co., Ltd. 799.3 Million CNY 24.649%
Walvax Biotechnology Co., Ltd. 4.11 Billion CNY 85.359%
Sunflower Pharmaceutical Group Co.,Ltd 5.63 Billion CNY 89.306%
Harbin Gloria Pharmaceuticals Co., Ltd 2.58 Billion CNY 76.745%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. 24.73 Billion CNY 97.565%
Hunan Hansen Pharmaceutical Co., Ltd. 955.53 Million CNY 36.969%
Changzhou Qianhong Biopharma CO.,LTD 1.79 Billion CNY 66.425%
Shenzhen Weiguang Biological Products Co., Ltd. 1.04 Billion CNY 42.558%
Honz Pharmaceutical Co., Ltd. 739.56 Million CNY 18.563%
Northeast Pharmaceutical Group Co., Ltd. 8.16 Billion CNY 92.62%
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd 1.46 Billion CNY 58.823%
Guizhou Xinbang Pharmaceutical Co., Ltd. 6.46 Billion CNY 90.678%
Tianjin Lisheng Pharmaceutical Co.,Ltd. 1.13 Billion CNY 46.708%
Zhejiang Yatai Pharmaceutical Co., Ltd. 420.64 Million CNY -43.182%
Zhejiang NHU Company Ltd. 15.11 Billion CNY 96.016%
ApicHope Pharmaceutical Co., Ltd 2.5 Billion CNY 75.942%
Shanghai Kaibao Pharmaceutical CO.,Ltd 1.59 Billion CNY 62.217%
Beijing SL Pharmaceutical Co., Ltd. 1.01 Billion CNY 40.857%
Yunnan Baiyao Group Co.,Ltd 38.9 Billion CNY 98.452%
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD 1.08 Billion CNY 44.236%
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. 839.25 Million CNY 28.236%
Guangdong Lifestrong Pharmacy Co., Ltd. 292.39 Million CNY -105.982%
Huadong Medicine Co., Ltd 40.39 Billion CNY 98.509%
Jiangsu Nhwa Pharmaceutical Co., LTD 4.97 Billion CNY 87.89%
Harbin Medisan Pharmaceutical Co., Ltd. 1.18 Billion CNY 49.251%
LanZhou Foci Pharmaceutical Co.,Ltd. 1.16 Billion CNY 48.219%
Tianjin Chase Sun Pharmaceutical Co.,Ltd 6.12 Billion CNY 90.17%
Beijing Beilu Pharmaceutical Co., Ltd 890.71 Million CNY 32.382%
Nanjing Hicin Pharmaceutical Co., Ltd. 517.83 Million CNY -16.309%
Renhe Pharmacy Co., Ltd. 5.03 Billion CNY 88.031%
Chongqing Pharscin Pharmaceutical Co., Ltd. 691.54 Million CNY 12.907%
Zhejiang Xianju Pharmaceutical Co.,Ltd. 4.12 Billion CNY 85.394%
Luoxin Pharmaceuticals Group Stock Co., Ltd. 2.34 Billion CNY 74.29%
Guizhou Bailing Group Pharmaceutical Co., Ltd. 4.26 Billion CNY 85.872%